References

1. Pape U-F, Berndt U, Müller-Nordhorn J et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2008 Dec;15(4):1083-1097. PubMed | Google Scholar


2. .Bosman FT, Carneiro F, Hruban RH et al. WHO classification of tumours of the digestive System. Fourth Edition. Accessed October 14, 2017


3. Ohmoto A, Rokutan H, Yachida S. Pancreatic neuroendocrine neoplasms: basic biology, current treatment strategies and prospects for the future. Int J Mol Sci. 2017 Jan 13;18(1). pii: E14. PubMed | Google Scholar


4. Khan M, Luong T, Watkins J et al. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer. 2013 May 14;108(9):1838-1845. PubMed | Google Scholar


5. Fesinmeyer MD, Austin MA, Li CI et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1766-1773. PubMed | Google Scholar


6. Halfdanarson T, Rabe K, Rubin J, Petersen G. Pancreatic endocrine tumors (PETs): Incidence and recent trend toward improved survival. Journal of Clinical Oncology. 2007 June; 25(18) suppl: 4584-4584. Google Scholar